feed,title,long_url,short_url
🔐MarketWatch,Coronavirus Update: Novavax’s protein-based vaccine approval fails to boost stock as demand for shots and boosters remains low,http://www.marketwatch.com/news/story.asp?guid=%7B20C05575-04D4-B545-7FA6-D8A92132F3E8%7D&siteid=rss&rss=1,https://on.mktw.net/3aB5rnk
